CoChat

β 1 ‐ and β 2 ‐adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non‐failing adult human heart

Open access
Brito‐Martins, M, Harding, S E, Ali, N N · 2008 · British Journal of Pharmacology

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Background and purpose: Characterization of human embryonic stem cell‐derived cardiomyocytes (hESC‐CM) in relation to adult myocytes is essential for their future use in transplantation or as a model system. The β‐adrenoceptor pathways, which are known to be effective early in hESC‐CM development, are of major importance because of their control of rate and force of beating, arrhythmia generation and apoptosis/necrosis. We have therefore performed detailed pharmacological analysis of the β‐adrenoceptor responses in developing hESC‐CM. Experimental approach: hESC‐CMs were differentiated from H7 ESCs and studied up to 79 days of differentiation. Rate of beating and time course of contraction and relaxation were measured in superfused preparations. Key results: Responses to the mixed β 1 ‐ and β 2 ‐adrenoceptor agonist isoprenaline were evident from day 10 to day 79. Stability of the responses during an application, for repeated applications on the same experimental day and over the time of development, was determined. Concentrations for half‐maximal response (12.9 n M ) were similar to those from adult human heart, but closer to those obtained from failing rather than normal ventricle. Acceleration of both contraction and relaxation was quantitatively similar to that in adult ventricular myocytes, as was sensitivity to muscarinic inhibition. Use of specific antagonists showed that both β 1 ‐ and β 2 ‐adrenoceptors contributed to contractile responses, as seen with adult myocytes. Conclusions and implications: These data show the compatibility of hESC‐CM with adult human myocardium in terms of β‐adrenoceptor response. The experiments described here also confirm the utility of the hESC‐CM preparation for detailed pharmacological analysis. British Journal of Pharmacology (2008) 153 , 751–759; doi: 10.1038/sj.bjp.0707619 ; published online 14 January 2008

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0707619

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 88

Metadata

Authors
Brito‐Martins, M., Harding, S. E., & Ali, N. N.
Affiliations
Imperial College London (GB)
Corresponding author
Harding, S E
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2008-02
Volume
153
Issue
4
Pages
751-759
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2013721243
Cited by
74
References
31
Citations by year
2025: 3 · 2024: 3 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 3 · 2015: 4 · 2014: 7 · 2013: 2 · 2012: 10
FWCI
3.29
Type
journal article
Language
en
Open access
Licence
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Centre for the Replacement, Refinement and Reduction of Animals in Research (G0600373/1)
  • Biotechnology and Biological Sciences Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
Keywords
human embryonic stem cell-derived cardiomyocytes, beta1-adrenergic receptor, beta2-adrenergic receptor, isoproterenol, cardiomyocyte differentiation, beating frequency, heart failure, ventricular myocytes, adrenergic signaling
MeSH terms
Adrenergic beta-Agonists, Adrenergic beta-Antagonists, Adult, Animals, Carbachol, Cell Differentiation, Cell Line, Dose-Response Relationship, Drug, Heart Failure, Humans, Imidazoles, Isoproterenol, Myocardial Contraction, Propanolamines, Receptors, Muscarinic, Time Factors, Receptors, Adrenergic, beta-1, Receptors, Adrenergic, beta-2, Muscarinic Agonists, Cell Lineage, Myocytes, Cardiac, Stem Cell Transplantation, Mice, Embryonic Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.